(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
N/A | ||
(Address of principal executive offices) | (Zip Code) |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||
☒ | Accelerated filer | ☐ | |
Non-accelerated filer | ☐ | Smaller reporting company | |
Emerging growth company | |||
Page | |
Cautionary Note Regarding Forward-Looking Statements | |
PART I | |
Item 1. Business | |
Item 1A. Risk Factors | |
Item 1B. Unresolved Staff Comments | |
Item 1C. Cybersecurity | |
Item 2. Properties | |
Item 3. Legal Proceedings | |
Item 4. Mine Safety Disclosures | |
PART II | |
Item 5. Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities | |
Item 6. [Reserved] | |
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations | |
Item 7A. Quantitative and Qualitative Disclosures About Market Risk | |
Item 8. Financial Statements and Supplementary Data | |
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure | |
Item 9A. Controls and Procedures | |
Item 9B. Other Information | |
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections | |
PART III | |
Item 10. Directors, Executive Officers and Corporate Governance | |
Item 11. Executive Compensation | |
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters | |
Item 13. Certain Relationships and Related Transactions, and Director Independence | |
Item 14. Principal Accountant Fees and Services | |
PART IV | |
Item 15. Exhibits, Financial Statement Schedules | |
Item 16. Form 10-K Summary | |
Signatures |
Number of Facilities | ||||||
Segment | Owned | Leased | Total | |||
North America | 157 | 151 | 308 | |||
Europe, MEA and APAC | 246 | 51 | 297 | |||
LATAM | 54 | 9 | 63 | |||
Corporate and significant regional offices | 1 | 5 | 6 | |||
Total (1) | 458 | 216 | 674 | |||
Location of Mill | Containerboard | Paperboard | Kraft Paper | Pulp | Total | |||||
Mahrt, AL | 1,031 | 1,031 | ||||||||
Longview, WA | 624 | 351 | 975 | |||||||
Fernandina Beach, FL | 928 | 928 | ||||||||
West Point, VA | 922 | 922 | ||||||||
Stevenson, AL | 864 | 864 | ||||||||
Covington, VA | 793 | 793 | ||||||||
Hodge, LA | 790 | 790 | ||||||||
Solvay, NY | 770 | 770 | ||||||||
Florence, SC | 733 | 733 | ||||||||
Seminole, FL | 620 | 620 | ||||||||
Evadale, TX | 55 | 531 | 586 | |||||||
Dublin, GA | 279 | 305 | 584 | |||||||
Roanoke Rapids, NC | 322 | 196 | 518 | |||||||
Demopolis, AL | 374 | 100 | 474 | |||||||
La Tuque, Quebec | 341 | 127 | 468 | |||||||
Hopewell, VA | 466 | 466 | ||||||||
Monterrey, MX | 402 | 402 | ||||||||
Cerro Gordo, MX | 259 | 88 | 347 | |||||||
Guadalajara, MX | 160 | 110 | 270 | |||||||
San Pablo, MX | 243 | 243 | ||||||||
Cowpens, SC | 234 | 234 | ||||||||
Los Reyes, MX | 158 | 158 | ||||||||
Battle Creek, MI | 150 | 150 | ||||||||
Dallas, TX | 127 | 127 | ||||||||
Missisquoi, VT | 99 | 99 | ||||||||
Stroudsburg, PA | 72 | 72 | ||||||||
San Luis Potosi, MX | 71 | 71 | ||||||||
Total North America | 9,241 | 3,502 | 852 | 100 | 13,695 |
Location of Mill | Containerboard | Paperboard | Kraft Paper | Graphic Paper | Total | |||||
Piteå, SWE | 794 | 794 | ||||||||
Roermond, NETH | 717 | 717 | ||||||||
Parenco, NETH | 441 | 248 | 689 | |||||||
Facture, FRA | 634 | 634 | ||||||||
Zulpich, GER | 573 | 573 | ||||||||
Hoya, GER | 474 | 88 | 562 | |||||||
Verzuolo, ITA | 551 | 551 | ||||||||
Nettingsdorf, AUS | 507 | 507 | ||||||||
Wrexen, GER | 259 | 88 | 347 | |||||||
Herzberg, GER | 287 | 287 | ||||||||
Saillat, FRA | 281 | 281 | ||||||||
Mengibar, SPA | 265 | 265 | ||||||||
Townsend Hook, U.K. | 259 | 259 | ||||||||
Ania, ITA | 254 | 254 | ||||||||
SSK, U.K. | 220 | 220 | ||||||||
Nervion, SPA | 176 | 176 | ||||||||
Morai, IND | 165 | 165 | ||||||||
Belgrade, SER | 132 | 132 | ||||||||
Navarra, SPA | 94 | 94 | ||||||||
Morava, CZK | 83 | 83 | ||||||||
Rethel, FRA | 72 | 72 | ||||||||
Total Europe, MEA and APAC | 6,681 | 463 | 270 | 248 | 7,662 |
Location of Mill | Containerboard | Paperboard | Kraft Paper | Total | ||||
Tres Barras, BRA | 650 | 650 | ||||||
Cali, COL | 129 | 70 | 121 | 320 | ||||
Pirapetinga, BRA | 143 | 143 | ||||||
Barbosa, COL | 127 | 127 | ||||||
Bernal, ARG | 77 | 77 | ||||||
Barranquilla, COL | 77 | 77 | ||||||
Uberaba, BRA | 72 | 72 | ||||||
Coronel Suarez, ARG | 57 | 57 | ||||||
Bento, BRA | 55 | 55 | ||||||
Total LATAM | 1,387 | 70 | 121 | 1,578 |

Years ended December 31, | |||
2025 | 2024 | ||
Net sales | $31,179 | $21,109 | |
Cost of goods sold | (25,136) | (16,914) | |
Gross profit | 6,043 | 4,195 | |
Selling, general and administrative expenses | (3,819) | (2,737) | |
Impairment and restructuring costs | (385) | (56) | |
Transaction and integration-related expenses associated with the Combination | (120) | (395) | |
Operating profit | 1,719 | 1,007 | |
Interest expense, net | (729) | (398) | |
Pension and other postretirement non-service income (expense), net | 30 | (24) | |
Other expense, net | (61) | (25) | |
Income before income taxes | 959 | 560 | |
Income tax expense | (260) | (241) | |
Net income | 699 | 319 | |
Net income attributable to noncontrolling interests | — | — | |
Net income attributable to common shareholders | $699 | $319 | |
Years ended December 31, | |||
2025 | 2024 | ||
Net sales (aggregate):(1) | |||
North America | $18,577 | $10,092 | |
Europe, MEA and APAC | 10,893 | 9,577 | |
LATAM | 2,113 | 1,711 | |
Segment Adjusted EBITDA: | |||
North America | $2,998 | $1,610 | |
Europe, MEA and APAC | 1,618 | 1,529 | |
LATAM | 485 | 378 | |
Years ended December 31, | |||
($ in millions) | |||
2025 | 2024 | ||
Net cash provided by operating activities | $3,392 | $1,483 | |
Net cash used for investing activities | $(2,143) | $(2,114) | |
Net cash (used for) provided by financing activities | $(1,298) | $607 | |
Years ended December 31, | |||
2025 | 2024 | ||
Net income | $699 | $319 | |
Income tax expense | 260 | 241 | |
Depreciation, depletion and amortization | 2,550 | 1,464 | |
Impairment and restructuring costs | 385 | 56 | |
Transaction and integration-related expenses associated with the Combination | 120 | 395 | |
Amortization of fair value step up on inventory | — | 224 | |
Interest expense, net | 729 | 398 | |
Pension and other postretirement non-service (income) expense, net | (30) | 24 | |
Share-based compensation expense | 139 | 206 | |
Other expense, net | 61 | 25 | |
Other adjustments | 26 | 34 | |
Adjusted EBITDA | $4,939 | $3,386 | |
SUMMARIZED STATEMENT OF OPERATIONS | Year ended December 31, |
2025 | |
Net sales to unrelated parties | $1,445 |
Net sales to Non-Obligor Subsidiaries | 1,162 |
Gross profit | 878 |
Interest expense, net with unrelated parties | (634) |
Interest expense, net with Non-Obligor Subsidiaries | (345) |
Net income and net income attributable to the Obligor Group | 963 |
SUMMARIZED BALANCE SHEETS | December 31, | December 31, | |
2025 | 2024 | ||
ASSETS | |||
Current amounts due from Non-Obligor Subsidiaries | $4,571 | $4,925 | |
Other current assets | 1,207 | 1,049 | |
Total current assets | $5,778 | $5,974 | |
Non-current amounts due from Non-Obligor Subsidiaries | $3,355 | $2,848 | |
Other non-current assets | 918 | 370 | |
Total non-current assets | $4,273 | $3,218 | |
LIABILITIES | |||
Current amounts due to Non-Obligor Subsidiaries | $9,130 | $9,681 | |
Other current liabilities | 482 | 1,122 | |
Total current liabilities | $9,612 | $10,803 | |
Non-current amounts due to Non-Obligor Subsidiaries | $7,447 | $6,604 | |
Other non-current liabilities | 11,823 | 9,644 | |
Total non-current liabilities | $19,270 | $16,248 |
Defined Benefit Pension Plans | |||
50 Basis Point Increase | 50 Basis Point Decrease | ||
Discount rate | $8 | $(8) | |
Compensation level | 1 | (1) | |
Expected long-term rate of return on plan assets | (35) | 35 | |
Page | |
Report of Independent Registered Public Accounting Firm (Auditor Name PCAOB ID: | |
Consolidated Balance Sheets as of December 31, 2025 and December 31, 2024 | |
Consolidated Statements of Operations for the years ended December 31, 2025, December 31, 2024 and December 31, 2023 | |
Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2025, December 31, 2024 and December 31, 2023 | |
Consolidated Statements of Cash Flows for the years ended December 31, 2025, December 31, 2024 and December 31, 2023 | |
Consolidated Statements of Changes in Equity for the years ended December 31, 2025, December 31, 2024 and December 31, 2023 | |
Notes to Consolidated Financial Statements |
December 31, 2025 | December 31, 2024 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents (amounts related to consolidated variable interest entities of $ $ | $ | $ | |
Accounts receivable, net (amounts related to consolidated variable interest entities of $ $ | |||
Inventories | |||
Other current assets | |||
Total current assets | |||
Property, plant and equipment, net | |||
Goodwill | |||
Intangibles, net | |||
Prepaid pension asset | |||
Other non-current assets (amounts related to consolidated variable interest entities of $ $ | |||
Total assets | $ | $ | |
Liabilities and Equity | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Accrued expenses | |||
Accrued compensation and benefits | |||
Current portion of debt | |||
Other current liabilities | |||
Total current liabilities | |||
Non-current debt due after one year (amounts related to consolidated variable interest entities of $ | |||
Deferred tax liabilities | |||
Pension liabilities and other postretirement benefits, net of current portion | |||
Other non-current liabilities (amounts related to consolidated variable interest entities of $ and $ | |||
Total liabilities | |||
Commitments and Contingencies (Note 21) | |||
Equity: | |||
Preferred stock, $ | |||
Common stock, $ shares outstanding at December 31, 2025 and December 31, 2024, respectively | |||
Deferred shares, € December 31, 2025 and December 31, 2024, respectively | |||
Treasury stock, at cost; December 31, 2024, respectively | ( | ( | |
Capital in excess of par value | |||
Accumulated other comprehensive loss | ( | ( | |
Retained earnings | |||
Total shareholders’ equity | |||
Noncontrolling interests | |||
Total equity | |||
Total liabilities and equity | $ | $ |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Net sales | $ | $ | $ | ||
Cost of goods sold | ( | ( | ( | ||
Gross profit | |||||
Selling, general and administrative expenses | ( | ( | ( | ||
Impairment and restructuring costs | ( | ( | ( | ||
Transaction and integration-related expenses associated with the Combination | ( | ( | ( | ||
Operating profit | |||||
Interest expense, net | ( | ( | ( | ||
Pension and other postretirement non-service income (expense), net | ( | ( | |||
Other expense, net | ( | ( | ( | ||
Income before income taxes | |||||
Income tax expense | ( | ( | ( | ||
Net income | |||||
Net income attributable to noncontrolling interests | ( | ||||
Net income attributable to common shareholders | $ | $ | $ | ||
Basic earnings per share attributable to common shareholders | $ | $ | $ | ||
Diluted earnings per share attributable to common shareholders | $ | $ | $ | ||
The accompanying notes are an integral part of these Consolidated Financial Statements. | |||||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Net income | $ | $ | $ | ||
Other comprehensive income (loss), net of tax: | |||||
Foreign currency translation gain (loss) | ( | ||||
Defined benefit pension and other postretirement benefit plans | ( | ( | |||
Net (loss) gain on cash flow hedges | ( | ||||
Other comprehensive income (loss), net of tax | ( | ||||
Comprehensive income (loss) | ( | ||||
Comprehensive income attributable to noncontrolling interests | ( | ||||
Comprehensive income (loss) attributable to common shareholders | $ | $( | $ | ||
The accompanying notes are an integral part of these Consolidated Financial Statements. | |||||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Operating activities: | |||||
Net income | $ | $ | $ | ||
Adjustments to reconcile consolidated net income to net cash provided by operating activities: | |||||
Depreciation, depletion and amortization | |||||
Cash surrender value increase in excess of premiums paid | ( | ( | |||
Impairment charges | |||||
Share-based compensation expense | |||||
Deferred income tax benefit | ( | ( | ( | ||
Pension and other postretirement funding more than cost | ( | ( | ( | ||
Other | ( | ||||
Change in operating assets and liabilities, net of acquisitions and divestitures: | |||||
Accounts receivable | ( | ||||
Inventories | |||||
Other assets | ( | ( | |||
Accounts payable | ( | ( | ( | ||
Income taxes | ( | ( | ( | ||
Accrued liabilities and other | ( | ||||
Net cash provided by operating activities | |||||
Investing activities: | |||||
Capital expenditures | ( | ( | ( | ||
Cash paid for purchase of businesses, net of cash acquired | ( | ( | ( | ||
Proceeds from corporate owned life insurance | |||||
Proceeds from sale of property, plant and equipment | |||||
Other | |||||
Net cash used for investing activities | ( | ( | ( | ||
Financing activities: | |||||
Additions to debt | |||||
Repayments of debt | ( | ( | ( | ||
Debt issuance costs | ( | ( | |||
Changes in commercial paper, net | ( | ||||
Other debt (repayments) additions, net | ( | ( | |||
Repayments of finance lease liabilities | ( | ( | ( | ||
Tax paid in connection with shares withheld from employees | ( | ( | |||
Purchases of treasury stock | ( | ( | |||
Cash dividends paid to shareholders | ( | ( | ( | ||
Other | ( | ( | |||
Net cash (used for) provided by financing activities | ( | ( | |||
Effect of exchange rate changes on cash and cash equivalents | ( | ||||
Increase (decrease) in cash and cash equivalents | ( | ||||
Cash and cash equivalents at January 1 | |||||
Cash and cash equivalents at December 31 | $ | $ | $ | ||
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest (“NCI”) | Total | |
Balance at December 31, 2022(1) | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | ||||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Issuance of common stock | — | — | — | — | — | — | — | — | |
Purchases of treasury stock | — | — | — | ( | — | — | ( | — | ( |
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Dividends declared ($ | — | — | — | — | ( | — | ( | — | ( |
Balance at December 31, 2023 | ( | ( | |||||||
Net income | — | — | — | — | — | — | |||
Other comprehensive loss, net of tax | — | — | — | — | — | ( | ( | — | ( |
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Purchases of treasury stock | — | — | — | ( | — | — | ( | — | ( |
Shares of Smurfit Westrock common stock issued to WestRock shareholders and NCI assumed as a result of the Merger | — | — | — | ||||||
Converted WestRock RSUs and Options attributable to pre- Combination services | — | — | — | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Reclassification from retained earnings to accumulated other comprehensive loss | — | — | — | — | ( | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at December 31, 2024 | ( | ( | |||||||
Net income | — | — | — | — | — | — | |||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Cancellation of deferred shares by Smurfit Kappa Employee Trust | — | — | — | ( | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at December 31, 2025 | $ | $ | $( | $ | $( | $ | $ | $ |
2025 | 2024 | ||
Outstanding payment obligations at January 1 | $ | $ | |
Assumed as part of the Combination | |||
Amounts added during the period | |||
Amounts settled during the period | ( | ( | |
Outstanding payment obligations at December 31 | $ | $ |
Cash paid for outstanding WestRock Stock(1) | $ |
Smurfit Westrock Shares issued to WestRock Shareholders(2) | |
Converted WestRock Options and WestRock RSU Awards attributable to pre-Combination service(3) | |
Settlement of pre-existing relationships, trade and other payable and receivable balances with WestRock(4) | ( |
Aggregate Merger Consideration | $ |
Preliminary Allocation | Measurement Period Adjustments | Final Allocation | |||
Identifiable net assets: | |||||
Cash and cash equivalents | $ | $ | $ | ||
Accounts receivable | |||||
Inventories | |||||
Other current assets | ( | ||||
Property, plant and equipment | |||||
Intangibles | |||||
Prepaid pension asset | |||||
Other non-current assets | |||||
Accounts payable | ( | ( | |||
Accrued compensation and benefits | ( | ( | |||
Current portion of debt | ( | ( | |||
Other current liabilities | ( | ( | ( | ||
Non-current debt due after one year | ( | ( | ( | ||
Deferred tax liabilities | ( | ( | |||
Pension liabilities and other postretirement benefits, net of current portion | ( | ( | |||
Other non-current liabilities | ( | ( | ( | ||
Noncontrolling interests | ( | ( | |||
Identifiable net assets acquired as of July 5, 2024 | |||||
Goodwill arising on Merger | ( | ||||
Aggregate Merger Consideration | $ | $ | $ |
Fair Value | Weighted Average Useful Lives (in years) | ||
Customer relationships | $ | ||
Trade names and trademarks | |||
Developed technology | |||
Software assets | |||
Land use rights | |||
Intangible assets acquired | $ |
Years ended December 31, | |||
2024 | 2023 | ||
Net sales | $ | $ | |
Net income (loss) attributable to common shareholders | $ | $( | |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Net sales (unaffiliated customers) | |||||
Ireland (country of domicile) | $ | $ | $ | ||
U.S. | |||||
Mexico | |||||
Germany | |||||
France | |||||
Other Americas | |||||
Other Europe, MEA and APAC | |||||
Total | $ | $ | $ | ||
December 31, | |||
2025 | 2024 | ||
Long-lived assets(1) | |||
Ireland (country of domicile) | $ | $ | |
U.S. | |||
Other Americas | |||
Other Europe, MEA and APAC | |||
Total | $ | $ | |
Year ended December 31, 2025 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Year ended December 31, 2024 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Amortization of fair value step up on inventory | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service expense, net | ( | ||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Year ended December 31, 2023 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service expense, net | ( | ||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Income before income taxes | $ |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Capital expenditures: | |||||
North America | $ | $ | $ | ||
Europe, MEA and APAC | |||||
LATAM | |||||
Total per reportable segments | |||||
Corporate | |||||
Total capital expenditures | $ | $ | $ | ||
December 31, | |||
2025 | 2024 | ||
Assets: | |||
North America | $ | $ | |
Europe, MEA and APAC | |||
LATAM | |||
Total reportable segments | |||
Corporate(1) | |||
Total assets | $ | $ | |
Year ended December 31, 2025 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Year ended December 31, 2024 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Year ended December 31, 2023 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Impairment charges | $ | $ | $ | ||
Restructuring costs | |||||
Impairment and restructuring costs | $ | $ | $ | ||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Impairment of property, plant and equipment | $ | $ | $ | ||
Impairment of other assets | |||||
Total impairment charges | $ | $ | $ | ||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
North America | $ | $ | $ | ||
Europe, MEA and APAC | |||||
LATAM | |||||
Total impairment charges recognized for property, plant and equipment | $ | $ | $ | ||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
North America | $ | $ | $ | ||
Europe, MEA and APAC | |||||
LATAM | |||||
Total restructuring costs | $ | $ | $ | ||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Severance charges | $ | $ | $ | ||
Other costs | |||||
Total restructuring costs | $ | $ | $ | ||
Severance charges | Other costs | Total | |||
Balance at December 31, 2024 | $ | $ | $ | ||
Charges for the period | |||||
Payments | ( | ( | ( | ||
Balance at December 31, 2025 | $ | $ | $ |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Transaction-related reversals (expenses) associated with the Combination | $ | $( | $( | ||
Integration-related (expenses) associated with the Combination | ( | ( | |||
Total transaction and integration-related expenses associated with the Combination | $( | $( | $( | ||
December 31, | |||
2025 | 2024 | ||
Gross accounts receivable | $ | $ | |
Less: Allowances | ( | ( | |
Accounts receivable | $ | $ | |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Balance at January 1 | $ | $ | $ | ||
Charges to net sales and selling, general and administrative expenses | |||||
Deductions | ( | ( | ( | ||
Write offs | ( | ( | ( | ||
Balance at December 31 | $ | $ | $ | ||
December 31, | |||
2025 | 2024 | ||
Finished goods | $ | $ | |
Work-in-progress | |||
Raw materials | |||
Consumables and spare parts | |||
Inventories | $ | $ | |
December 31, | |||
2025 | 2024 | ||
Land and buildings | $ | $ | |
Plant and equipment | |||
Construction-in-progress | |||
Finance lease right-of-use assets | |||
Property, plant and equipment at cost, excluding forestlands | |||
Less: Accumulated depreciation and impairment | ( | ( | |
Property, plant and equipment, net, excluding forestlands | |||
Forestlands, net of depletion | |||
Property, plant and equipment, net | $ | $ | |
North America | Europe, MEA and APAC | LATAM | Total | ||||
Balance as of December 31, 2023 | $ | $ | $ | $ | |||
Acquisitions and acquisitions adjustments | |||||||
Translation adjustment | ( | ( | ( | ( | |||
Balance as of December 31, 2024 | |||||||
Acquisitions and acquisitions adjustments | ( | ( | |||||
Translation adjustment | |||||||
Balance as of December 31, 2025 | $ | $ | $ | $ |
December 31, | |||||||
2025 | 2024 | ||||||
Gross Carrying Amount | Accumulated Amortization | Gross Carrying Amount | Accumulated Amortization | ||||
Customer relationships | $ | $( | $ | $( | |||
Trade names and trademarks | ( | ( | |||||
Developed technology | ( | ( | |||||
Software assets | ( | ( | |||||
Land use rights | |||||||
Total | $ | $( | $ | $( | |||
Year ended December 31, | Total | |
2026 | $ | |
2027 | ||
2028 | ||
2029 | ||
2030 |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Interest expense | $( | $( | $( | ||
Interest income | |||||
Interest expense, net | $( | $( | $( | ||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Operating lease costs | $( | $( | $( | ||
Variable and short-term lease costs | ( | ( | ( | ||
Finance lease cost: | |||||
Amortization of lease assets | ( | ( | ( | ||
Interest on lease liabilities | ( | ( | ( | ||
Total lease costs | $( | $( | $( | ||
Balance Sheet Location | December 31, | ||||
2025 | 2024 | ||||
Operating leases: | |||||
Operating lease right-of-use assets | Other non-current assets | $ | $ | ||
Current operating lease liabilities | Other current liabilities | $ | $ | ||
Non-current operating lease liabilities | Other non-current liabilities | ||||
Total operating lease liabilities | $ | $ | |||
Finance leases: | |||||
Property, plant and equipment | Property, plant and equipment, net | $ | $ | ||
Accumulated amortization | ( | ( | |||
Property, plant and equipment, net | $ | $ | |||
Current finance lease liabilities | Current portion of debt | $ | $ | ||
Non-current finance lease liabilities | Non-current debt due after one year | ||||
Total finance lease liabilities | $ | $ | |||
December 31, | |||
2025 | 2024 | ||
Weighted average remaining lease term: | |||
Operating leases | |||
Finance leases | |||
Weighted average discount rate: | |||
Operating leases | |||
Finance leases | |||
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Cash paid for amounts included in the measurement of lease liabilities: | |||||
Operating cash flows related to operating leases | $ | $ | $ | ||
Operating cash flows related to finance leases | |||||
Financing cash flows related to finance leases | |||||
Leased assets obtained in exchange for lease liabilities: | |||||
Operating leases | $ | $ | $ | ||
Finance leases | $ | $ | $ | ||
Year ended December 31, | Operating Leases | Finance Leases | Total | |||
2026 | $ | $ | $ | |||
2027 | ||||||
2028 | ||||||
2029 | ||||||
2030 | ||||||
Thereafter | ||||||
Total lease payments | $ | $ | $ | |||
Less: Interest | ( | ( | ( | |||
Present value of future lease payments | $ | $ | $ |
December 31, | |||||||
2025 | 2024 | ||||||
Book Value | Fair Value | Book Value | Fair Value | ||||
Debt with fixed interest rates | $ | $ | $ | $ | |||
Level 1 | Level 2 | ||||||
December 31, | December 31, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Assets | |||||||
Other Investments: | |||||||
Listed | $ | $ | $ | $ | |||
Unlisted | |||||||
Derivatives in cash flow hedging relationships | |||||||
Derivatives not designated as hedging instruments | |||||||
Assets measured at fair value | $ | $ | $ | $ | |||
Liabilities | |||||||
Derivatives in cash flow hedging relationships | $ | $ | $ | $ | |||
Derivatives not designated as hedging instruments | |||||||
Liabilities measured at fair value | $ | $ | $ | $ | |||
Years ended December 31, | |||
2025 | 2024 | ||
Receivable from financial institutions at January 1 | $ | $ | |
Receivables sold to the financial institutions and derecognized | ( | ( | |
Receivables collected by financial institutions | |||
Cash (payments) proceeds (to) from financial institutions | ( | ||
Receivable from financial institutions at December 31 | $ | $ | |
December 31, | |||||||
2025 | 2024 | ||||||
Amount | Weighted average interest rate | Amount | Weighted average interest rate | ||||
$ | $ | $ | |||||
$ | |||||||
$ | |||||||
€ | |||||||
$ | |||||||
$ | |||||||
$ | |||||||
€ | |||||||
€ | |||||||
€ | |||||||
$ | |||||||
$ | |||||||
$ | |||||||
€ | |||||||
$ | |||||||
$ | |||||||
€ | |||||||
$ | |||||||
€ | |||||||
$ | |||||||
$ | |||||||
$ | |||||||
€ | |||||||
$ | |||||||
$ | |||||||
$ | |||||||
Commercial paper | |||||||
Vendor financing and commercial card programs | |||||||
Farm credit facility | |||||||
Other bank loans | |||||||
Finance lease obligations | |||||||
Total debt, excluding fair value adjustments, bond discounts and debt issuance costs | |||||||
Unamortized fair value adjustments, bond discounts and debt issuance costs | ( | ( | |||||
Total debt | |||||||
Less: Current portion of debt | ( | ( | |||||
Non-current debt due after one year | $ | $ | |||||
Year ended December 31, | Total | |
2026 | $ | |
2027 | ||
2028 | ||
2029 | ||
2030 | ||
2031 and thereafter | ||
Unamortized fair value adjustments, bond discounts and debt issuance costs | ( | |
Total | $ |
2025 | 2024 | ||
Within one year | $ | $ | |
Between one and two years | |||
More than two years |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Deferred Bonus Plan | $ | $ | $ | ||
Performance Share Plan | |||||
Performance Share Units | |||||
Restricted Stock Units | |||||
Total share-based compensation expense | $ | $ | $ | ||
Income tax benefit related to share-based compensation expense | $ | $ | $ | ||
Number of shares | Weighted average grant date fair value | ||
Outstanding at January 1 | $ | ||
Granted | |||
Forfeited | ( | ||
Vested | ( | ||
Outstanding at December 31 | $ |
2025 | 2024 | ||
Risk-free interest rate | |||
Expected volatility | |||
Expected term (years) |
Number of shares | Weighted average grant date fair value | ||
Outstanding at January 1 | $ | ||
Granted | |||
Forfeited | ( | ||
Vested | ( | ||
Outstanding at December 31 | $ |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Income before income taxes: | |||||
Domestic (Ireland) | $ | $ | $ | ||
Foreign (U.S.) | ( | ( | ( | ||
Foreign (Other) | |||||
Total income before income taxes | $ | $ | $ | ||
Income tax expense consists of the following components: | |||||
Current tax expense (net of investment tax credits of $ | |||||
Domestic (Ireland) | $ | $ | $ | ||
Foreign (U.S., Federal & State) | |||||
Foreign (Other) | |||||
Total current tax expense | $ | $ | $ | ||
Deferred tax expense (benefit): | |||||
Domestic (Ireland) | $( | $ | $ | ||
Foreign (U.S., Federal & State) | ( | ( | |||
Foreign (Other) | ( | ( | ( | ||
Total deferred tax benefit | ( | ( | ( | ||
Total income tax expense | $ | $ | $ | ||
Total income tax expense consists of the following components: | |||||
Domestic (Ireland) | $ | $ | $ | ||
Foreign (U.S., Federal & State) | ( | ( | |||
Foreign (Other) | |||||
Total income tax expense | $ | $ | $ | ||
Year ended December 31, | |||
2025 | |||
Income before income taxes | $ | ||
Ireland corporate tax rate | |||
Foreign tax effects | |||
United States | |||
Statutory tax rate difference between United States and Ireland | ( | ( | |
State and local taxes, net of federal benefit | ( | ( | |
Change in valuation allowances | |||
Effects of cross border tax laws - GILTI | |||
Effects of cross border tax laws - Subpart F | |||
Nontaxable company-owned life insurance (COLI) | ( | ( | |
R&D tax credits | ( | ( | |
Other | |||
Mexico | |||
Statutory tax rate difference between Mexico and Ireland | |||
Tax benefits associated with inflation deductions | ( | ( | |
Other | |||
Brazil | |||
Statutory tax rate difference between Brazil and Ireland | |||
Other | ( | ( | |
France | |||
Statutory tax rate difference between France and Ireland | |||
Corporate surtax | |||
Other | |||
Spain | |||
Statutory tax rate difference between Spain and Ireland | |||
Other | ( | ( | |
Colombia | |||
Statutory tax rate difference between Colombia and Ireland | |||
Other | ( | ( | |
Germany | |||
Local corporate trade tax | ( | ( | |
Other | |||
Netherlands | |||
Tax expense from foreign currency exchange transactions | |||
Austria | |||
Statutory tax rate difference between Austria and Ireland | |||
Other | |||
Sweden | |||
Statutory tax rate difference between Sweden and Ireland | |||
Other | |||
Other foreign jurisdictions | |||
Nontaxable or nondeductible items | |||
Nondeductible interest expense | |||
Changes in unrecognized tax benefits | ( | ( | |
Other | |||
Corporate earnings subject to Ireland | |||
Other | |||
Effective tax rate | $ | ||
Years ended December 31, | |||
2024 | 2023 | ||
Income before income taxes | $ | $ | |
Income before income taxes multiplied by the statutory income tax rate | |||
Effects of: | |||
Income subject to different rates of tax | |||
Change related to outside basis difference in foreign subsidiaries | |||
Change in valuation allowance | ( | ||
Uncertain tax positions | |||
U.S. state and local taxes | ( | ||
Ireland non-deductible interest | |||
Non-deductible U.S. executive compensation | |||
Non-deductible transaction costs | |||
Other items | ( | ( | |
Income tax expense | $ | $ | |
December 31, | |||
2025 | 2024 | ||
Deferred tax assets: | |||
Pension liabilities and other postretirement benefits | $ | $ | |
Carryforwards | |||
Lease liabilities | |||
Accrued expenses | |||
Stock-based compensation | |||
Other | |||
Total | |||
Deferred tax liabilities: | |||
Property, plant and equipment | ( | ( | |
Investments in subsidiaries | ( | ( | |
Prepaid pension asset | ( | ( | |
Intangibles | ( | ( | |
Inventory reserves | ( | ( | |
Other non-current assets | ( | ( | |
Other | ( | ( | |
Total | ( | ( | |
Valuation allowances | ( | ( | |
Net deferred tax liability | $( | $( | |
2025 | 2024 | 2023 | |||
Balance at January 1 | $ | $ | $ | ||
Increases through continuing operations | |||||
Reductions through continuing operations | ( | ( | ( | ||
Net change in the valuation allowance through continuing operations | ( | ||||
Valuation allowances assumed as part of the Combination | |||||
Net change in the valuation allowance | ( | ||||
Balance at December 31 | $ | $ | $ |
2025 | 2024 | 2023 | |||
Balance at January 1 | $ | $ | $ | ||
Additions for tax positions taken in current year | |||||
Unrecognized tax benefits acquired as part of the Combination | |||||
Additions for tax positions taken in prior years | |||||
Reductions for tax positions taken in prior years | ( | ||||
Reductions due to settlements | ( | ( | |||
Currency translation adjustments | ( | ||||
Reductions as a result of a lapse of the applicable statute of limitations | ( | ( | ( | ||
Balance at December 31 | $ | $ | $ |
Year ended December 31, | |
2025 | |
Domestic | |
Ireland | $ |
Foreign | |
Netherlands | |
Mexico | |
France | |
Colombia | |
United States, Federal | |
Brazil | |
Sweden | |
Spain | |
Austria | |
Other | |
Total Foreign | |
Total income tax paid, net of refunds | $ |
Defined Benefit Pension Plans | |||||||
U.S. Plans | Non-U.S. Plans | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Change in projected benefit obligation: | |||||||
Benefit obligation at January 1 | $ | $ | $ | $ | |||
Service cost | |||||||
Interest cost | |||||||
Plan amendments | ( | ||||||
Actuarial loss (gain) | ( | ( | ( | ||||
Benefits paid | ( | ( | ( | ( | |||
Plan participant contributions | |||||||
Curtailments | ( | ( | |||||
Settlements | ( | ( | |||||
Acquisitions | |||||||
Other items | ( | ||||||
Foreign currency rate changes | ( | ||||||
Benefit obligation at December 31 | $ | $ | $ | $ | |||
Change in plan assets: | |||||||
Fair value of plan assets at January 1 | $ | $ | $ | $ | |||
Actual gain on plan assets | |||||||
Employer contributions | |||||||
Plan participant contributions | |||||||
Benefits paid | ( | ( | ( | ( | |||
Settlements | ( | ( | |||||
Acquisitions | |||||||
Other items | ( | ||||||
Foreign currency rate changes | ( | ||||||
Fair value of plan assets at December 31 | $ | $ | $ | $ | |||
Funded status at December 31 | $ | $ | $( | $( | |||
Amounts recognized in the Consolidated Balance Sheets: | |||||||
Non-current assets | $ | $ | $ | $ | |||
Current liabilities | ( | ( | ( | ( | |||
Non-current liabilities | ( | ( | ( | ( | |||
Funded status at December 31 | $ | $ | $( | $( | |||
Accumulated Benefit Obligation | $ | $ | $ | $ | |||
Defined Benefit Pension Plans | |||||||
U.S. Plans | Non-U.S. Plans | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net actuarial loss | $ | $ | $ | $ | |||
Prior service cost (credit) | ( | ( | |||||
Total accumulated other comprehensive loss | $ | $ | $ | $ | |||
Defined Benefit Pension Plans | |||||||
U.S. Plans | Non-U.S. Plans | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Plans with projected benefit obligations in excess of plan assets: | |||||||
Projected benefit obligation | $ | $ | $ | $ | |||
Accumulated benefit obligation | |||||||
Fair value of plan assets | |||||||
Plans with accumulated benefit obligations in excess of plan assets: | |||||||
Accumulated benefit obligation | $ | $ | $ | $ | |||
Fair value of plan assets | |||||||
Defined Benefit Pension Plans | |||||||||||
U.S. Plans | Non-U.S. Plans | ||||||||||
2025 | 2024 | 2023 | 2025 | 2024 | 2023 | ||||||
Service cost | $ | $ | $ | $ | $ | $ | |||||
Interest cost | |||||||||||
Expected return on assets | ( | ( | ( | ( | ( | ( | |||||
Amortization of: | |||||||||||
Net actuarial (gain) loss | ( | ||||||||||
Prior service credit | ( | ( | ( | ||||||||
Curtailment gain | ( | ( | |||||||||
Settlement loss | |||||||||||
Net periodic benefit (income) cost | $( | $( | $( | $ | $ | $ | |||||
Defined Benefit Pension Plans | |||||||
U.S. Plans | Non-U.S. Plans | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Discount rate | |||||||
Rate of compensation increase | |||||||
Interest crediting rates | |||||||
Defined Benefit Pension Plans | |||||||||||
U.S. Plans | Non-U.S. Plans | ||||||||||
2025 | 2024 | 2023 | 2025 | 2024 | 2023 | ||||||
Discount rate | |||||||||||
Rate of compensation increase | |||||||||||
Expected long-term rate of return on plan assets | |||||||||||
Interest crediting rates | |||||||||||
Defined Benefit Pension Plans | |||
U.S. Plans | Non-U.S. Plans | ||
2025 | 2025 | ||
Equities | |||
Fixed Income | |||
Real Estate | |||
Other (incl. Liability-Driven Investments (“LDI”)) | |||
Defined Benefit Pension Plans | |||||||||||
U.S. Plans | |||||||||||
2025 | 2024 | ||||||||||
Asset Class | Quoted Prices in Active Markets For Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Total | Quoted Prices in Active Markets For Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Total | |||||
Cash | $ | $ | $ | $ | $ | $ | |||||
Equity | |||||||||||
Government Bonds | |||||||||||
Corporate Bonds | |||||||||||
Other (incl. LDI) | |||||||||||
Total assets measured using fair value hierarchy | $ | $ | $ | $ | $ | $ | |||||
Assets measured at NAV | |||||||||||
Total assets | $ | $ | |||||||||
Defined Benefit Pension Plans | |||||||||||||||
Non-U.S. Plans | |||||||||||||||
2025 | 2024 | ||||||||||||||
Asset Class | Quoted Prices in Active Markets For Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Total | Quoted Prices in Active Markets For Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Total | |||||||
Cash | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Equity | |||||||||||||||
Government Bonds | |||||||||||||||
Corporate Bonds | |||||||||||||||
Other (incl. LDI) | ( | ||||||||||||||
Total assets measured using fair value hierarchy | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Assets measured at NAV | |||||||||||||||
Total assets | $ | $ | |||||||||||||
Year ended December 31, | Defined Benefit Pension Plans | |
2026 | $ | |
2027 | ||
2028 | ||
2029 | ||
2030 | ||
2031-2035 |
Years ended December 31, | |||||
2025 | 2024 | 2023 | |||
Numerator: | |||||
Net income attributable to common shareholders | $ | $ | $ | ||
Denominator: | |||||
Basic weighted average shares outstanding | |||||
Effect of dilutive share options | |||||
Diluted weighted average shares outstanding | |||||
Basic earnings per share attributable to common shareholders | $ | $ | $ | ||
Diluted earnings per share attributable to common shareholders | $ | $ | $ | ||
Year ended December 31, | Total | |
2026 | $ | |
2027 | ||
2028 | ||
2029 | ||
2030 | ||
Thereafter | ||
Total | $ |
December 31, | |||
2025 | 2024 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ | $ | |
Accounts receivable | |||
Inventories | |||
Other current assets | |||
Non-current assets: | |||
Property, plant and equipment, net | |||
Other non-current assets | |||
Total assets | $ | $ | |
Liabilities | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Current portion of debt | |||
Other current liabilities | |||
Non-current liabilities: | |||
Non-current debt due after one year | |||
Other non-current liabilities | |||
Total liabilities | $ | $ | |
Foreign Currency Translation | Cash Flow Hedges | Defined Benefit Pension and Other Postretirement Benefit Plans | Other Adjustments(1) | Total(2) | |
Balance at December 31, 2022 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | ( | ||
Balance at December 31, 2023 | $ | $ | $ | $( | $ |
Other comprehensive loss (income) | ( | ||||
Reclassification from retained earnings | ( | ( | |||
Balance at December 31, 2024 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | |||
Balance at December 31, 2025 | $ | $ | $ | $( | $ |
Years ended December 31, | |||||||||||
2025 | 2024 | 2023 | |||||||||
Pre-Tax | Tax | Net of Tax | Pre-Tax | Tax | Net of Tax | Pre-Tax | Tax | Net of Tax | |||
Foreign currency translation gain (loss) | $ | $ | $ | $( | $ | $( | $ | $ | $ | ||
Defined benefit pension and other postretirement benefit plans: | |||||||||||
Net actuarial (loss) gain arising during year | ( | ( | ( | ( | ( | ||||||
Amortization and settlement recognition of net actuarial loss | ( | ( | ( | ||||||||
Prior service (cost) credit arising during year | ( | ( | ( | ( | ( | ||||||
Amortization of prior service credit | ( | ( | ( | ( | ( | ( | |||||
Foreign currency (loss) gain - pensions | ( | ( | ( | ( | |||||||
Changes in fair value of cash flow hedges | ( | ( | |||||||||
Consolidated other comprehensive income (loss) | ( | ( | ( | ||||||||
Other comprehensive loss (income) attributable to noncontrolling interests | |||||||||||
Other comprehensive income (loss) attributable to common shareholders | $ | $ | $ | $( | $( | $( | $ | $ | $ | ||
Exhibit Number | Description of Exhibit | ||
3.1 | |||
4.1 | |||
4.2 | |||
4.3 | |||
4.4† | |||
4.5 | |||
4.6 | |||
4.7 | |||
4.18 | |||
4.19 | |||
4.20 | |||
4.21† | |||
4.22 | Form of Indenture, dated as of March 1, 1983, between MWV (formerly Westvaco Corporation) and The Bank of New York (formerly Irving Trust Company), as trustee (incorporated by reference to Exhibit 2 of Westvaco Corporation’s Registration Statement on Form 8-A filed on January 24, 1984). | ||
4.23 | First Supplemental Indenture, dated as of January 31, 2002, to the Indenture dated as of March 1, 1983, by and among MWV (as successor-in-interest to Westvaco Corporation and The Mead Corporation) and The Bank of New York, as | ||
4.24 | |||
4.25 | |||
4.26 | |||
4.27 | |||
4.28† | |||
4.29 |
10.6+ | |||
10.7 | |||
10.8 | |||
10.9 | |||
10.10 | |||
10.11 | |||
10.12 | |||
10.13 | Second CoBank Amendment, dated as of July 1, 2024, by and among WestRock, the CoBank Credit Facility Borrower and certain other subsidiaries of WestRock from time to time party thereto, Smurfit Westrock, Smurfit Kappa and certain subsidiaries of Smurfit Kappa, as guarantors, the lenders from time to time party thereto and CoBank, ACB, as | ||
10.14^ | |||
10.15# | |||
10.16# | Form of PSU Award Agreement (2024 Award) under the Smurfit Westrock plc 2024 Long-Term Incentive Plan | ||
10.17# | Form of RSU Award Agreement (Non-Executive Directors) under the Smurfit Westrock plc 2024 Long-Term Incentive | ||
10.18# |
10.19# | |||
10.20# | |||
10.21# | |||
10.22# | |||
10.23# | |||
10.24# | |||
10.25# | |||
10.26# | |||
10.27# | |||
10.28# | |||
10.29# | |||
10.30# | |||
10.31# | |||
10.32# | |||
10.33# | |||
10.34# | |||
10.35 | |||
10.36# | |||
10.37# | |||
10.38# | |||
10.39# | |||
19.1 | |||
21† | |||
22† | |||
23† | Consent of KPMG, Independent Registered Public Accounting Firm. | ||
24 | Power of Attorney (included on signature page). | ||
31.1† | |||
31.2† | |||
32†* | |||
97 | |||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.** | ||
101.SCH | Inline XBRL Taxonomy Extension Schema.** | ||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase.** | ||
101.DEF | Inline XBRL Taxonomy Extension Definition Document.** | ||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase.** | ||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase.** | ||
104 | Cover Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
† | Filed or furnished herewith. |
* | The certification furnished in Exhibit 32 hereto is deemed to accompany this Annual Report on Form 10-K and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference. Such certification will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference. |
** | Submitted electronically herewith. |
+ | Certain identified information has been excluded from this exhibit because it is not material and is of the type that the Company treats as private or confidential. |
^ | Annexes, schedules and/or exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. |
# | Management contract or compensatory plan or arrangement. |
Smurfit Westrock plc | ||
Dated: February 27, 2026 | /s/ Anthony Smurfit | |
Name: | Anthony Smurfit | |
Title: | President & Group Chief Executive Officer | |
(Principal Executive Officer) | ||
Signature | Title | Date | ||
/s/ Anthony Smurfit | President & Group Chief Executive Officer and Director | February 27, 2026 | ||
Anthony Smurfit | (Principal Executive Officer) | |||
/s/ Ken Bowles | Executive Vice President & Group Chief Financial Officer and Director | February 27, 2026 | ||
Ken Bowles | (Principal Financial Officer) | |||
/s/ Irene Page | Chief Accounting Officer | February 27, 2026 | ||
Irene Page | (Principal Accounting Officer) | |||
/s/ Irial Finan | Director | February 27, 2026 | ||
Irial Finan | ||||
/s/ Kaisa Hietala | Director | February 27, 2026 | ||
Kaisa Hietala | ||||
/s/ Colleen F. Arnold | Director | February 27, 2026 | ||
Colleen F. Arnold | ||||
/s/ Timothy J. Bernlohr | Director | February 27, 2026 | ||
Timothy J. Bernlohr | ||||
/s/ Carole L. Brown | Director | February 27, 2026 | ||
Carole L. Brown | ||||
/s/ Terrell K. Crews | Director | February 27, 2026 | ||
Terrell K. Crews | ||||
/s/ Carol Fairweather | Director | February 27, 2026 | ||
Carol Fairweather | ||||
/s/ Mary Lynn Ferguson-McHugh | Director | February 27, 2026 | ||
Mary Lynn Ferguson-McHugh | ||||
/s/ Suzan F. Harrison | Director | February 27, 2026 | ||
Suzan F. Harrison | ||||
/s/ Lourdes Melgar | Director | February 27, 2026 | ||
Lourdes Melgar | ||||
/s/ Jørgen Buhl Rasmussen | Director | February 27, 2026 | ||
Jørgen Buhl Rasmussen | ||||
/s/ Alan D. Wilson | Director | February 27, 2026 | ||
Alan D. Wilson |